LIST OF TABLES
TABLE 01.U.S. TOPICAL PAIN RELIEF MARKET, BY THERAPEUTIC CLASS, 2019–2027 ($MILLION)
TABLE 02.U.S. TOPICAL NON-OPIOIDS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.U.S. TOPICAL OPIOIDS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 04.U.S. TOPICAL PAIN RELIEF MARKET, BY FORMULATION, 2019–2027 ($MILLION)
TABLE 05.U.S. TOPICAL PAIN RELIEF MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 06.U.S. TOPICAL PAIN RELIEF MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 07.ADVACARE: COMPANY SNAPSHOT
TABLE 08.ADVACARE: BUSINESS SEGMENTS
TABLE 09.ADVACARE: PRODUCT PORTFOLIO
TABLE 10.GSK: COMPANY SNAPSHOT
TABLE 11.GLAXOSMITHKLINE PLC.: OERATING SEGMENT
TABLE 12.GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
TABLE 13.GSK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 14.J&J: COMPANY SNAPSHOT
TABLE 15.J&J: OPERATING SEGMENTS
TABLE 16.J&J: PRODUCT PORTFOLIO
TABLE 17.NESTLÉ: COMPANY SNAPSHOT
TABLE 18.NESTLÉ: OPERATING SEGMENTS
TABLE 19.NESTLÉ: PRODUCT PORTFOLIO
TABLE 20.NOVARTIS: COMPANY SNAPSHOT
TABLE 21.NOVARTIS: OPERATING SEGMENT
TABLE 22.NOVARTIS: PRODUCT PORTFOLIO
TABLE 23.PFIZER: COMPANY SNAPSHOT
TABLE 24.PFIZER: OPERATING SEGMENT
TABLE 25.PFIZER: PRODUCT PORTFOLIO
TABLE 26.RB: COMPANY SNAPSHOT
TABLE 27.RB: OPERATING SEGMENTS
TABLE 28.RB: PRODUCT PORTFOLIO
TABLE 29.SANOFI: COMPANY SNAPSHOT
TABLE 30.SANOFI: OPERATING SEGMENT
TABLE 31.SANOFI: PRODUCT PORTFOLIO
TABLE 32.SUN PHARMA: COMPANY SNAPSHOT
TABLE 33.SUN PHARMA: OPERATING SEGMENTS
TABLE 34.SUN PHARMA: PRODUCT PORTFOLIO
TABLE 35.TOPICAL BIOMEDICS: COMPANY SNAPSHOT
TABLE 36.TOPICAL BIOMEDICS: OPERATING SEGMENTS
TABLE 37.TOPICAL BIOMEDICS: PRODUCT PORTFOLIO LIST OF FIGURES
FIGURE 01.U.S. TOPICAL PAIN RELIEF MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 04.HIGH BARGAINING POWER OF BUYERS
FIGURE 05.HIGH THREAT OF SUBSTITUTES
FIGURE 06.HIGH THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE INTENSITY OF RIVALRY
FIGURE 08.NUMBER OF ELDERLY POPULATION (ADULT 65+) IN THE U.S., 2020-2060 (MILLION)
FIGURE 09.IMPACT ANALYSIS: U.S. TOPICAL PAIN RELIEF MARKET
FIGURE 10.U.S. TOPICAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, 2019–2027 ($MILLION)
FIGURE 11.U.S. TOPICAL METHYL SALICYLATES MARKET, 2019–2027 ($MILLION)
FIGURE 12.U.S. TOPICAL CAPSAICIN MARKET, 2019–2027 ($MILLION)
FIGURE 13.U.S. TOPICAL LIDOCAINE MARKET, 2019–2027 ($MILLION)
FIGURE 14.U.S. TOPICAL OTHER NON-OPIOIDS MARKET, 2019–2027 ($MILLION)
FIGURE 15.U.S. TOPICAL BUPRENORPHINE MARKET, 2019–2027 ($MILLION)
FIGURE 16.U.S. TOPICAL FENTANYL MARKET, 2019–2027 ($MILLION)
FIGURE 17.U.S. TOPICAL PAIN RELIEF CREAM MEDICATIONS MARKET, 2019–2027 ($MILLION)
FIGURE 18.U.S. TOPICAL PAIN RELIEF GEL MARKET, 2019–2027 ($MILLION)
FIGURE 19.U.S. TOPICAL PAIN RELIEF SPRAY MARKET, 2019–2027 ($MILLION)
FIGURE 20.U.S. TOPICAL PAIN RELIEF PATCH MARKET, 2019–2027 ($MILLION)
FIGURE 21.U.S. OTHERS TOPICAL PAIN RELIEF MARKET, 2019–2027 ($MILLION)
FIGURE 22.U.S. PRESCRIPTION PAIN RELIEF TOPICAL PAIN RELIEF MARKET, 2019–2027 ($MILLION)
FIGURE 23.U.S. PHARMACIES & DRUG STORES TOPICAL PAIN RELIEF MARKET, 2019–2027 ($MILLION)
FIGURE 24.U.S. E-COMMERCE TOPICAL PAIN RELIEF MARKET, 2019–2027 ($MILLION)
FIGURE 25.U.S. RETAIL & GROCERY STORES TOPICAL PAIN RELIEF MARKET, 2019–2027 ($MILLION)
FIGURE 26.GSK: NET SALES, 2017–2019 ($MILLION)
FIGURE 27.GSK: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 28.GSK: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 29.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 30.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 31.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 32.NESTLÉ: REVENUE, 2017–2019 ($MILLION)
FIGURE 33.NESTLÉ: REVENUE SHARE BY OPERATING SEGMENT, 2019 (%)
FIGURE 34.NESTLÉ.: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 35.NOVARTIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 36.NOVARTIS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 37.NOVARTIS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 38.PFIZER: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.PFIZER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 40.PFIZER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.RB: REVENUE, 2017–2019 ($MILLION)
FIGURE 42.RB: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43.RB: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 44.SANOFI.: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.SANOFI: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 46.SANOFI: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 47.SUN PHARMA: NET SALES, 2017–2019 ($MILLION)
FIGURE 48.SUN PHARMA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 49.SUN PHARMA: REVENUE SHARE BY REGION, 2019 (%